Olopatadine Hydrochloride/Ketorolac trometamol

盐酸奥洛他定/酮咯酸氨丁三醇

Report date: 2026/05/27 14:29:22

Base Information

Drug NameOlopatadine Hydrochloride/Ketorolac trometamol

Drug Alias NameOlopatadine Hydrochloride+Ketorolac trometamol盐酸奥洛他定和酮咯酸氨丁三醇olopatadine + ketorolac酮咯酸氨丁三醇/盐酸奥洛他定olopatadine hydrochloride + ketorolac tromethamine +[14]

ClassificationSmall molecules

Mechanisms of ActionHistamine H1 receptor antagonistsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors

TargetsCyclooxygenase-2Histamine H1 receptorCyclooxygenase-1

Therapy Area/IndicationsConjunctivitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsYes Ketorolac Tromethamine Olotadine Hydrochloride

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAllergan Plc

China Registration ClassN/A

Develop Information

Active CompaniesAllergan Plc

Inactive CompaniesN/A

Active IndicationsConjunctivitis, Allergic

Inactive IndicationsN/A

Other Information

ATC CodeS01GX